In the standard form of modified ECT, the short-acting muscle relaxant used is?

NORCET 3 - 2022 (Shift-1)

Pharmacology

Easy

Appeared in: NORCET 3 - 2022 (Shift-1)

Explanation

Succinylcholine is an ultra-short-acting depolarizing muscle relaxant, making it the drug of choice for modified ECT.
Its rapid onset of action (within 1 minute) and short duration (3-5 minutes) align perfectly with the brief nature of an ECT-induced seizure.
The primary purpose is to prevent severe muscle contractions during the seizure, thereby avoiding musculoskeletal injuries such as fractures or dislocations.
Its short half-life allows for a quick return of spontaneous respiration after the procedure, enhancing patient safety.

Option B: Pancuronium is a long-acting muscle relaxant with a duration of 60 minutes or more. Its prolonged effect would necessitate extended mechanical ventilation, making it unsuitable for a brief procedure like ECT.
Option C: Atropine is an anticholinergic agent, not a muscle relaxant. Its function in ECT is to manage secretions and prevent bradycardia.
Option D: Thiopental is a general anesthetic used to induce unconsciousness. It does not provide muscle relaxation.

Visual 1: Flowchart: Sequence of Drug Administration in Modified ECT. This would visually map the order: 1. Anticholinergic (e.g., Atropine), 2. Anesthetic (e.g., Thiopental), 3. Muscle Relaxant (Succinylcholine), followed by the electrical stimulus.
Visual 2: Table: Comparison of Muscle Relaxants. This table would compare Succinylcholine, Pancuronium, and Rocuronium based on onset, duration, and mechanism of action, highlighting why Succinylcholine is ideal for ECT.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Pharmacotherapy in Modified Electroconvulsive Therapy (ECT) as background academic context rather than a clinical decision trigger.
Understanding the specific roles of each drug in ECT is crucial for patient safety. Administering the wrong drug or dose can lead to prolonged apnea, cardiovascular complications, or inadequate seizure modification.
Nurses play a vital role in preparing the patient, monitoring for side effects, and managing the post-procedure recovery. This includes recognizing the signs of adverse reactions to any of the medications used.
What if the patient has a known pseudocholinesterase deficiency? In this case, Succinylcholine would be contraindicated because its metabolism would be impaired, leading to prolonged paralysis and apnea. An alternative non-depolarizing agent like rocuronium (with its reversal agent, sugammadex) or atracurium would be used instead.

How to Approach the Question

First, identify the core of the question: it asks for a specific type of drug (short-acting muscle relaxant) used in a specific procedure (modified ECT).
Recall the standard protocol for modified ECT. This involves a sequence of medications to ensure patient safety and comfort.
Differentiate between the drug classes provided in the options: muscle relaxants, anticholinergics, and anesthetics.
Eliminate options that are not muscle relaxants (Atropine, Thiopental).
Between the remaining muscle relaxants (Succinylcholine, Pancuronium), compare their duration of action. The question specifies 'short-acting', which points directly to Succinylcholine as the correct choice for the brief ECT procedure.

Concept Tested & Keywords

Q_W1gajKtLl3alB4OeaJbq